[PHARMA] QoQ TTM Result on 31-Dec-2009 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Feb-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Dec-2009 [#4]
Profit Trend
QoQ- 7.36%
YoY- 0.27%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Revenue 1,326,138 1,321,763 1,304,640 1,300,796 1,305,133 1,289,459 1,309,712 0.83%
PBT 75,653 69,675 73,685 81,438 78,444 86,658 83,409 -6.29%
Tax -21,273 -17,335 -17,340 -19,709 -20,911 -24,472 -26,289 -13.15%
NP 54,380 52,340 56,345 61,729 57,533 62,186 57,120 -3.22%
-
NP to SH 54,554 52,027 54,977 60,192 56,067 60,598 56,008 -1.73%
-
Tax Rate 28.12% 24.88% 23.53% 24.20% 26.66% 28.24% 31.52% -
Total Cost 1,271,758 1,269,423 1,248,295 1,239,067 1,247,600 1,227,273 1,252,592 1.01%
-
Net Worth 424,488 417,065 439,675 431,217 407,858 400,161 402,378 3.62%
Dividend
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Div 89,852 118,755 97,382 97,382 86,673 57,770 48,140 51.53%
Div Payout % 164.70% 228.26% 177.13% 161.79% 154.59% 95.33% 85.95% -
Equity
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Net Worth 424,488 417,065 439,675 431,217 407,858 400,161 402,378 3.62%
NOSH 106,924 106,939 106,977 107,001 107,049 106,995 107,015 -0.05%
Ratio Analysis
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
NP Margin 4.10% 3.96% 4.32% 4.75% 4.41% 4.82% 4.36% -
ROE 12.85% 12.47% 12.50% 13.96% 13.75% 15.14% 13.92% -
Per Share
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
RPS 1,240.26 1,235.99 1,219.55 1,215.67 1,219.19 1,205.16 1,223.85 0.89%
EPS 51.02 48.65 51.39 56.25 52.37 56.64 52.34 -1.68%
DPS 84.00 111.00 91.00 91.00 81.00 54.00 45.00 51.54%
NAPS 3.97 3.90 4.11 4.03 3.81 3.74 3.76 3.68%
Adjusted Per Share Value based on latest NOSH - 107,001
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
RPS 92.01 91.71 90.52 90.26 90.56 89.47 90.87 0.83%
EPS 3.79 3.61 3.81 4.18 3.89 4.20 3.89 -1.71%
DPS 6.23 8.24 6.76 6.76 6.01 4.01 3.34 51.47%
NAPS 0.2945 0.2894 0.3051 0.2992 0.283 0.2777 0.2792 3.61%
Price Multiplier on Financial Quarter End Date
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Date 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 -
Price 4.98 4.98 4.27 4.00 4.09 3.80 3.45 -
P/RPS 0.40 0.40 0.35 0.33 0.34 0.32 0.28 26.81%
P/EPS 9.76 10.24 8.31 7.11 7.81 6.71 6.59 29.89%
EY 10.25 9.77 12.04 14.06 12.81 14.90 15.17 -22.98%
DY 16.87 22.29 21.31 22.75 19.80 14.21 13.04 18.71%
P/NAPS 1.25 1.28 1.04 0.99 1.07 1.02 0.92 22.64%
Price Multiplier on Announcement Date
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Date 04/11/10 11/08/10 26/05/10 19/02/10 13/11/09 21/08/09 08/05/09 -
Price 4.92 4.95 4.71 4.05 3.93 4.00 3.82 -
P/RPS 0.40 0.40 0.39 0.33 0.32 0.33 0.31 18.50%
P/EPS 9.64 10.17 9.16 7.20 7.50 7.06 7.30 20.34%
EY 10.37 9.83 10.91 13.89 13.33 14.16 13.70 -16.92%
DY 17.07 22.42 19.32 22.47 20.61 13.50 11.78 28.02%
P/NAPS 1.24 1.27 1.15 1.00 1.03 1.07 1.02 13.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment